Navellier & Associates »

Tg Therapeutics shares owned by Navellier & Associates

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Navellier & Associates from 13F filings

Historical chart of Navellier & Associates investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Navellier & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Navellier & Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $973k 29k 33.22